Stocks
Axsome Therapeutics (AXSM) Operating Income US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | -124.7 | -179.8 | -231.8 | -280.6 | -169.2 | -175.6 | |||
| Changes by years, y/y, % | +26% | +44% | +29% | +21% | -40% | +11.3% | |||
Axsome Therapeutics. Operating Income, bln rub
Axsome Therapeutics. Operating Income, changes, %
Axsome Therapeutics. Operating Income, sum by quarters, bln rub
Axsome Therapeutics (AXSM) Operating Income US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Operating Income, bln rub | -57.0 | -36.7 | -46.1 | -29.4 | -63.4 | -175.6 | ||
| Changes by years, y/y, % | -15% | -53% | -26% | -59% | +11% | |||
| Changes by quarters, q/q, % | -22% | -36% | +26% | -36% | +115% | |||
